ATE353664T1 - Hcg therapie zur behandlung von metastatischem brustkrebs - Google Patents

Hcg therapie zur behandlung von metastatischem brustkrebs

Info

Publication number
ATE353664T1
ATE353664T1 AT99967331T AT99967331T ATE353664T1 AT E353664 T1 ATE353664 T1 AT E353664T1 AT 99967331 T AT99967331 T AT 99967331T AT 99967331 T AT99967331 T AT 99967331T AT E353664 T1 ATE353664 T1 AT E353664T1
Authority
AT
Austria
Prior art keywords
treatment
breast cancer
metastatic breast
hcg therapy
hcg
Prior art date
Application number
AT99967331T
Other languages
English (en)
Inventor
Irma H Russo
Jose Russo
Giampiero Deluca
Jaak Ph Janssens
Original Assignee
Fox Chase Cancer Ct
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fox Chase Cancer Ct, Applied Research Systems filed Critical Fox Chase Cancer Ct
Application granted granted Critical
Publication of ATE353664T1 publication Critical patent/ATE353664T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99967331T 1998-12-15 1999-12-15 Hcg therapie zur behandlung von metastatischem brustkrebs ATE353664T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98123817A EP1013281A1 (de) 1998-12-15 1998-12-15 hCG Therapie für Behandlung von Brustkrebs

Publications (1)

Publication Number Publication Date
ATE353664T1 true ATE353664T1 (de) 2007-03-15

Family

ID=8233138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99967331T ATE353664T1 (de) 1998-12-15 1999-12-15 Hcg therapie zur behandlung von metastatischem brustkrebs

Country Status (16)

Country Link
US (1) US7183251B1 (de)
EP (2) EP1013281A1 (de)
JP (1) JP2003523311A (de)
AR (1) AR023726A1 (de)
AT (1) ATE353664T1 (de)
AU (1) AU781495B2 (de)
BR (1) BR9916221A (de)
CA (1) CA2351726A1 (de)
CY (1) CY1106525T1 (de)
DE (1) DE69935156T2 (de)
DK (1) DK1140147T3 (de)
ES (1) ES2277461T3 (de)
IL (2) IL143671A0 (de)
PT (1) PT1140147E (de)
SI (1) SI1140147T1 (de)
WO (1) WO2000035469A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2582567A1 (en) * 2004-10-07 2006-04-13 Stem Cell Therapeutics Corp. Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0578328B1 (de) 1983-11-02 1999-12-29 Applied Research Systems ARS Holding N.V. Produkte und Methoden für die Herstellung einer heterodimerer menschlicher LH mit einem Met42 Val55 alpha Untereinheit
US5677275A (en) 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin
US5700781A (en) 1994-10-04 1997-12-23 Harris; Pamela Jo Method for treating Kaposi's sarcoma and HIV infections
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin

Also Published As

Publication number Publication date
EP1013281A1 (de) 2000-06-28
ES2277461T3 (es) 2007-07-01
PT1140147E (pt) 2007-03-30
EP1140147A2 (de) 2001-10-10
CA2351726A1 (en) 2000-06-22
AU781495B2 (en) 2005-05-26
DK1140147T3 (da) 2007-03-26
WO2000035469A3 (en) 2000-09-14
IL143671A (en) 2009-08-03
WO2000035469A2 (en) 2000-06-22
DE69935156D1 (de) 2007-03-29
SI1140147T1 (sl) 2007-06-30
US7183251B1 (en) 2007-02-27
JP2003523311A (ja) 2003-08-05
DE69935156T2 (de) 2007-11-22
WO2000035469A9 (en) 2001-03-22
BR9916221A (pt) 2001-09-11
CY1106525T1 (el) 2012-01-25
EP1140147B1 (de) 2007-02-14
IL143671A0 (en) 2002-04-21
AU2363100A (en) 2000-07-03
AR023726A1 (es) 2002-09-04

Similar Documents

Publication Publication Date Title
NO20005864D0 (no) Quinasoler til behandling av hjernesvulst
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
ATE320257T1 (de) (s,s)-reboxetine zur behandlung chronischer schmerzen
ATE271038T1 (de) 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen
DE69926385D1 (de) Behandlung von geweben
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE69927823D1 (de) Hydrogel für die therapeutische behandlung von aneurysmas
ATE239509T1 (de) Konjugate zur behandlung von prostatakrebs
ID27191A (id) Metode untuk pengobatan insomnia
DE60229959D1 (de) Kombinationstherapie zur behandlung von krebs
DE60030554T8 (de) Verwendungen von et743 zur behandlung von krebs
IL132287A0 (en) Compositions and methods for the treatment and diagnosis of breast cancer
EP1175616A4 (de) Verfahren für die diagnose und die behandlung von metastatischen prostatatumoren
NO974972L (no) FremgangsmÕte for Õ hindre brystcancer
ATE353664T1 (de) Hcg therapie zur behandlung von metastatischem brustkrebs
EE200200479A (et) Eksemestaani kasutamine rinnavähi ravis
DE59704933D1 (de) Verwendung von PHMB zur Behandlung von Tumorerkrankungen
ATE250580T1 (de) Substituierte pyridino-arylpiperazine zur behandlung benigner prostatahyperplasie
PL350863A1 (en) Compositions and methods for the treatment and diagnosis of breast cancer
DE50011084D1 (de) Verwendung von azolen zur prävention von strahlen-induziertem hautkrebs
ATE218866T1 (de) Kombinationstherapie zur behandlung von aids
DE59911556D1 (de) Arzneimittel zur vermeidung oder behandlung von papillomavirus-spezifischem tumor
ATE226440T1 (de) Zusammensetzung zur behandlung von psoriasis
ATE204167T1 (de) Antikonvulsive derivate zur behandlung von psoriasis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1140147

Country of ref document: EP

EEIH Change in the person of patent owner